Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42950

CCDC138 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The CCDC138 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from near-haploid HAP1 cells, targeting the CCDC138 gene. CCDC138 encodes a coiled-coil protein essential for sperm flagellum assembly and ciliogenesis, functioning downstream of RFX2 and FOXJ1 and interacting with centrosomal coiled-coil proteins such as CEP135 and CEP250. This loss-of-function model is ideal for studying centrosome and cilia biology, elucidating ciliogenesis signaling pathways, performing high-throughput genetic screens, and exploring drug targets for male infertility. Representative assays include western blotting, immunofluorescence for centrosomal and ciliary markers, and co-immunoprecipitation of interacting partners.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    CCDC138

    Gene Identifier

    NCBI Gene ID 165055

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC138 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the near-haploid human HAP1 cell line, with targeted disruption of the CCDC138 gene. This loss-of-function model enables investigation of CCDC138, a coiled-coil protein critical for sperm flagellum assembly and ciliogenesis. The polyclonal format provides a heterogeneous pool of edited alleles for robust functional studies without clonal selection artifacts.

HAP1 cells originate from the KBM-7 chronic myeloid leukemia (CML) cell line, established from a male patient in blast crisis, and exhibit a near-haploid karyotype that simplifies genetic analyses. As immortalized leukemic myeloid progenitor cells, HAP1 cells retain key features of hematopoietic lineage while providing a stable, proliferative model for high-throughput perturbation screens. The near-haploid genome facilitates CRISPR-based knockout studies by reducing gene copy-number complications, making it a preferred platform for systematic investigation of gene function.

CCDC138 encodes a coiled-coil protein localizing to the manchette and sperm flagellum, essential for axoneme assembly and flagellar motility. It functions downstream of transcription factors RFX2 and FOXJ1, which regulate ciliary gene expression. CCDC138 interacts with IFT proteins and centrosomal coiled-coil proteins like CEP135 and CEP250, facilitating assembly of axonemal dynein complexes and sperm flagellar structural proteins including DNAH1 and AKAP4. Loss of CCDC138 disrupts these interactions, causing multiple morphological abnormalities of the sperm flagella (MMAF) and male infertility. CCDC138 also contributes to centrosome duplication and organization.

In HAP1 cells, the polyclonal CCDC138 knockout population serves as a powerful tool for dissecting centrosomal and ciliary functions. Despite its well-established role in spermatogenesis, the near-haploid background of HAP1 cells enables unambiguous assessment of CCDC138??s involvement in centrosome organization and ciliogenesis, processes often dysregulated in leukemia and other cancers. The simplified genetic landscape allows for precise mapping of genetic interactions and facilitates the identification of synthetic lethal relationships in drug discovery contexts.

This knockout model supports diverse assays: western blotting for CCDC138, immunofluorescence for centrosomal (??-tubulin) and ciliary (acetylated tubulin) markers, RT-qPCR for ciliogenic gene expression, and co-immunoprecipitation with IFT and centrosomal components. Applications include functional analyses of CCDC138 in centrosome and cilia biology, elucidation of RFX2/FOXJ1 signaling, high-throughput genetic screens for ciliary modifiers, and drug target discovery for male infertility. For technical support, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)